Literature DB >> 27025826

Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections.

Alan R Hauser1, Joan Mecsas2, Donald T Moir3.   

Abstract

The utility of conventional antibiotics for the treatment of bacterial infections has become increasingly strained due to increased rates of resistance coupled with reduced rates of development of new agents. As a result, multidrug-resistant, extensively drug-resistant, and pandrug-resistant bacterial strains are now frequently encountered. This has led to fears of a "postantibiotic era" in which many bacterial infections will be untreatable. Alternative nonantibiotic treatment strategies need to be explored to ensure that a robust pipeline of effective therapies is available to clinicians. In this review, we highlight some of the recent developments in this area, such as the targeting of bacterial virulence factors, utilization of bacteriophages to kill bacteria, and manipulation of the microbiome to combat infections.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  antivirulence therapy; bacteria; microbiome; phage therapy; secretion systems

Mesh:

Substances:

Year:  2016        PMID: 27025826      PMCID: PMC4901866          DOI: 10.1093/cid/ciw200

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  55 in total

1.  Identification of Inhibitors of Pseudomonas aeruginosa Exotoxin-S ADP-Ribosyltransferase Activity.

Authors:  Ana Filipa Pinto; Mahsa Ebrahimi; Michael Saleeb; Åke Forsberg; Mikael Elofsson; Herwig Schüler
Journal:  J Biomol Screen       Date:  2016-02-05

Review 2.  Novel approaches to combat bacterial biofilms.

Authors:  Christophe Beloin; Stéphane Renard; Jean-Marc Ghigo; David Lebeaux
Journal:  Curr Opin Pharmacol       Date:  2014-09-23       Impact factor: 5.547

3.  Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.

Authors:  Carlos E Milla; James F Chmiel; Frank J Accurso; Donald R VanDevanter; Michael W Konstan; Geoffrey Yarranton; David E Geller
Journal:  Pediatr Pulmonol       Date:  2013-09-09

Review 4.  The art of antibacterial warfare: Deception through interference with quorum sensing-mediated communication.

Authors:  Giordano Rampioni; Livia Leoni; Paul Williams
Journal:  Bioorg Chem       Date:  2014-04-21       Impact factor: 5.275

5.  Structure-based design of a heptavalent anthrax toxin inhibitor.

Authors:  Amit Joshi; Sandesh Kate; Vincent Poon; Dhananjoy Mondal; Mohan B Boggara; Arundhati Saraph; Jacob T Martin; Ryan McAlpine; Ryan Day; Angel E Garcia; Jeremy Mogridge; Ravi S Kane
Journal:  Biomacromolecules       Date:  2011-02-08       Impact factor: 6.988

6.  Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization.

Authors:  Deborah T Hung; Elizabeth A Shakhnovich; Emily Pierson; John J Mekalanos
Journal:  Science       Date:  2005-10-13       Impact factor: 47.728

Review 7.  Probiotics as oral health biotherapeutics.

Authors:  Shyamali Saha; Catherine Tomaro-Duchesneau; Maryam Tabrizian; Satya Prakash
Journal:  Expert Opin Biol Ther       Date:  2012-06-13       Impact factor: 4.388

Review 8.  Bacteriophage lysins as effective antibacterials.

Authors:  Vincent A Fischetti
Journal:  Curr Opin Microbiol       Date:  2008-10-14       Impact factor: 7.934

9.  Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.

Authors:  Daniel B Gilmer; Jonathan E Schmitz; Chad W Euler; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

Review 10.  Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.

Authors:  Brad Spellberg; George H Talbot; Helen W Boucher; John S Bradley; David Gilbert; W Michael Scheld; John Edwards; John G Bartlett
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

View more
  36 in total

Review 1.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

Review 2.  Bacterial proteases, untapped antimicrobial drug targets.

Authors:  Elizabeth Culp; Gerard D Wright
Journal:  J Antibiot (Tokyo)       Date:  2016-11-30       Impact factor: 2.649

Review 3.  Carbon nanotubes as anti-bacterial agents.

Authors:  Teodora Mocan; Cristian T Matea; Teodora Pop; Ofelia Mosteanu; Anca Dana Buzoianu; Soimita Suciu; Cosmin Puia; Claudiu Zdrehus; Cornel Iancu; Lucian Mocan
Journal:  Cell Mol Life Sci       Date:  2017-05-23       Impact factor: 9.261

4.  In Vitro Detected hly II Cytotoxin in a Strain of Staphylococcus aureus (BM S-2) and Plant-Derived Aromatic Components: a Molecular Docking Study.

Authors:  Debadarshee Das Mohapatra; Smaranika Pattnaik; Sruti Panda
Journal:  Appl Biochem Biotechnol       Date:  2021-02-09       Impact factor: 2.926

Review 5.  The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship.

Authors:  Marin H Kollef; Matteo Bassetti; Bruno Francois; Jason Burnham; George Dimopoulos; Jose Garnacho-Montero; Jeffrey Lipman; Charles-Edouard Luyt; David P Nicolau; Maarten J Postma; Antonio Torres; Tobias Welte; Richard G Wunderink
Journal:  Intensive Care Med       Date:  2017-02-04       Impact factor: 17.440

6.  Small-Molecule Inhibitors of Haemophilus influenzae IgA1 Protease.

Authors:  Livia Shehaj; Santosh K Choudary; Kamlesh M Makwana; Mary C Gallo; Timothy F Murphy; Joshua A Kritzer
Journal:  ACS Infect Dis       Date:  2019-05-03       Impact factor: 5.084

7.  Investigation of Morchella esculenta and Morchella conica for their antibacterial potential against methicillin-susceptible Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Streptococcus pyogenes.

Authors:  Faiz Ul Haq; Muhammad Imran; Sidrah Saleem; Usman Aftab; Ayesha Ghazal
Journal:  Arch Microbiol       Date:  2022-06-14       Impact factor: 2.667

8.  Phosphatidylinositol 4,5-Bisphosphate-Dependent Oligomerization of the Pseudomonas aeruginosa Cytotoxin ExoU.

Authors:  Angelica Zhang; Jeffrey L Veesenmeyer; Alan R Hauser
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

9.  Characterization of a Salmonella Enteritidis bacteriophage showing broad lytic activity against Gram-negative enteric bacteria.

Authors:  Shukho Kim; Sung-Hun Kim; Marzia Rahman; Jungmin Kim
Journal:  J Microbiol       Date:  2018-10-25       Impact factor: 3.422

10.  Native Human Antibody to Shr Promotes Mice Survival After Intraperitoneal Challenge With Invasive Group A Streptococcus.

Authors:  Nilanjana Chatterjee; Ya-Shu Huang; Kristin V Lyles; Julie E Morgan; Lawrence M Kauvar; Susanna F Greer; Zehava Eichenbaum
Journal:  J Infect Dis       Date:  2021-04-23       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.